Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-006362
Filing Date
2024-09-10
Accepted
2024-09-10 10:41:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3375
  Complete submission text file 0001959173-24-006362.txt   4944
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Sebelius Kathleen (Reporting) CIK: 0001654316 (see all company filings)

Type: 144

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39532 | Film No.: 241289062
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)